Literature DB >> 23905893

Elevated PRAME expression: what does this mean for treatment of head and neck squamous cell carcinoma?

Miroslaw J Szczepanski1, Theresa L Whiteside.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23905893      PMCID： PMC3888223          DOI： 10.2217/bmm.13.68

Source DB:  PubMed          Journal:  Biomark Med        ISSN： 1752-0363            Impact factor:   2.851


× No keyword cloud information.
  23 in total

Review 1.  All trans retinoic acid and cancer.

Authors:  C Guruvayoorappan; V M Berlin Grace
Journal:  Immunopharmacol Immunotoxicol       Date:  2010-10-08       Impact factor: 2.730

Review 2.  Exploring biomarkers in head and neck cancer.

Authors:  Corey J Langer
Journal:  Cancer       Date:  2012-01-26       Impact factor: 6.860

Review 3.  Early detection of premalignant lesions and oral cancer.

Authors:  Toby O Steele; Arlen Meyers
Journal:  Otolaryngol Clin North Am       Date:  2011-02       Impact factor: 3.346

4.  Prognostic significance of p63, p53 and ki67 expression in laryngeal basaloid squamous cell carcinomas.

Authors:  C Calli; A Calli; E Pinar; S Oncel; B Tatar
Journal:  B-ENT       Date:  2011       Impact factor: 0.082

Review 5.  Retinoids regulate stem cell differentiation.

Authors:  Lorraine J Gudas; John A Wagner
Journal:  J Cell Physiol       Date:  2011-02       Impact factor: 6.384

6.  Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8⁺ T cells.

Authors:  Carmen Visus; Yangyang Wang; Antonio Lozano-Leon; Robert L Ferris; Susan Silver; Miroslaw J Szczepanski; Randall E Brand; Cristina R Ferrone; Theresa L Whiteside; Soldano Ferrone; Albert B DeLeo; Xinhui Wang
Journal:  Clin Cancer Res       Date:  2011-08-19       Impact factor: 12.531

7.  Inhibition of PRAME expression causes cell cycle arrest and apoptosis in leukemic cells.

Authors:  Norina Tanaka; Yan-Hua Wang; Masayuki Shiseki; Minoko Takanashi; Toshiko Motoji
Journal:  Leuk Res       Date:  2011-05-07       Impact factor: 3.156

Review 8.  A causal role for the human tumor antigen preferentially expressed antigen of melanoma in cancer.

Authors:  Mirjam T Epping; René Bernards
Journal:  Cancer Res       Date:  2006-11-15       Impact factor: 12.701

9.  Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin.

Authors:  R Lotan; X C Xu; S M Lippman; J Y Ro; J S Lee; J J Lee; W K Hong
Journal:  N Engl J Med       Date:  1995-05-25       Impact factor: 91.245

Review 10.  Chemoprevention strategies: the relevance of premalignant and malignant lesions of the upper aerodigestive tract.

Authors:  S P Schantz
Journal:  J Cell Biochem Suppl       Date:  1993
View more
  8 in total

1.  Impact of Preferentially Expressed Antigen of Melanoma on the Prognosis of Hepatocellular Carcinoma.

Authors:  Kenji Oyama; Keita Kanki; Hiroki Shimizu; Yohei Kono; Junya Azumi; Kan Toriguchi; Etsuro Hatano; Goshi Shiota
Journal:  Gastrointest Tumors       Date:  2016-08-03

Review 2.  The potential of tumor-derived exosomes for noninvasive cancer monitoring.

Authors:  Theresa L Whiteside
Journal:  Expert Rev Mol Diagn       Date:  2015-08-02       Impact factor: 5.225

3.  Diagnostic marker signature for esophageal cancer from transcriptome analysis.

Authors:  Ute Warnecke-Eberz; Ralf Metzger; Arnulf H Hölscher; Uta Drebber; Elfriede Bollschweiler
Journal:  Tumour Biol       Date:  2015-12-02

Review 4.  T-cell receptor-based therapy: an innovative therapeutic approach for solid tumors.

Authors:  Apostolia-Maria Tsimberidou; Karlyle Van Morris; Henry Hiep Vo; Stephen Eck; Yu-Feng Lin; Jorge Mauricio Rivas; Borje S Andersson
Journal:  J Hematol Oncol       Date:  2021-06-30       Impact factor: 17.388

5.  Preferentially Expressed Antigen of Melanoma Prevents Lung Cancer Metastasis.

Authors:  Quan Huang; Haifeng Wei; Zhipeng Wu; Lin Li; Liangfang Yao; Zhengwang Sun; Lei Li; Zaijun Lin; Wei Xu; Shuai Han; Wenjiao Cao; Yunfei Xu; Dianwen Song; Xinghai Yang; Jianru Xiao
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

6.  Identification of Preferentially Expressed Antigen of Melanoma as a Potential Tumor Suppressor in Lung Adenocarcinoma.

Authors:  Quan Huang; Lin Li; Zaijun Lin; Wei Xu; Shuai Han; Chenglong Zhao; Lei Li; Wenjiao Cao; Xinghai Yang; Haifeng Wei; Jianru Xiao
Journal:  Med Sci Monit       Date:  2016-05-31

7.  In Silico Design and Evaluation of PRAME+FliCΔD2D3 as a New Breast Cancer Vaccine Candidate.

Authors:  Mortaza Taheri-Anganeh; Amir Savardashtaki; Asma Vafadar; Ahmad Movahedpour; Zahra Shabaninejad; Amir Maleksabet; Ahmad Amiri; Younes Ghasemi; Cambyz Irajie
Journal:  Iran J Med Sci       Date:  2021-01

8.  PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer.

Authors:  Ghaneya Al-Khadairi; Adviti Naik; Remy Thomas; Boshra Al-Sulaiti; Shaheen Rizly; Julie Decock
Journal:  J Transl Med       Date:  2019-01-03       Impact factor: 5.531
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.